Boone Capital Management as of Dec. 31, 2025
Portfolio Holdings for Boone Capital Management
Boone Capital Management holds 15 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Medtronic SHS (MDT) | 12.9 | $41M | 429k | 96.06 | |
| Mirum Pharmaceuticals (MIRM) | 10.4 | $33M | 421k | 78.99 | |
| Ionis Pharmaceuticals (IONS) | 10.4 | $33M | 418k | 79.11 | |
| Cigna Corp (CI) | 8.3 | $27M | 97k | 275.23 | |
| BioMarin Pharmaceutical (BMRN) | 7.7 | $25M | 412k | 59.43 | |
| Neurocrine Biosciences (NBIX) | 6.8 | $22M | 152k | 141.83 | |
| UnitedHealth (UNH) | 6.4 | $20M | 62k | 330.11 | |
| Astrazeneca Sponsored Adr | 6.4 | $20M | 220k | 91.93 | |
| Healthequity (HQY) | 6.1 | $20M | 213k | 91.61 | |
| Livanova SHS (LIVN) | 5.6 | $18M | 289k | 61.53 | |
| Rapt Therapeutics Com New (RAPT) | 5.0 | $16M | 471k | 33.87 | |
| Bridgebio Pharma (BBIO) | 4.4 | $14M | 185k | 76.49 | |
| Kodiak Sciences (KOD) | 4.4 | $14M | 504k | 27.96 | |
| Tyra Biosciences (TYRA) | 3.3 | $11M | 399k | 26.29 | |
| Wave Life Sciences SHS (WVE) | 1.9 | $6.0M | 352k | 17.00 |
